A 12-month observational study on the safety, efficacy on migraine-associated symptoms and satisfaction of CGRP monoclonal antibodies in Japanese patients with migraineShungo Imai, Tsubasa Takizawa, Jin Nakahara et al.|Journal of the Neurological Sciences|2026Cited by 7